While measurement of
unconjugated estriol may be helpful in terms of evaluating a woman's risk of cancer (an «Estrogen Quotient» [estriol divided by the sum of estrone and estradiol] of ≤ 1.0 suggests lower cancer risk), its usefulness is significantly hampered because 90 % of estriol is conjugated.